Published in Vaccine Weekly, February 17th, 1997
The safety and immunogenicity clinical trial was sponsored by North American Vaccine and was conducted in conjunction with the Institute of Child Health at the University College London Medical School, London, United Kingdom. The results from the adult clinical study revealed that the meningococcal C polysaccharide conjugate vaccine was well-tolerated with minimal reactogenicity and no serious side-effects. Additionally, antibodies elicited by immunization with the conjugate...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly